- Investor's Business Daily•10 months ago
The European Union's medical advisory committee endorsed several key drugs from leading stocks Friday, making EU approval likely for some potential blockbusters: • The Committee for Medicinal Products ...
- Investor's Business Daily•last year
Top-rated specialty drugmaker Horizon Pharma beat first-quarter sales estimates and settled a patent suit, but its stock fell 6% to 27.62 on Friday. Horizon's (HZNP) earnings excluding one-time items rose ...
|Day's Range||0.00 - 0.00|
|Avg Vol (3m)||N/A|
As of 4:00 PM EDT. Market closed.